Intuitive Surgical, Inc. $ISRG Shares Acquired by Vermillion Wealth Management Inc.

Vermillion Wealth Management Inc. lifted its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 232.6% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 143 shares of the medical equipment provider’s stock after purchasing an additional 100 shares during the quarter. Vermillion Wealth Management Inc.’s holdings in Intuitive Surgical were worth $78,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in shares of Intuitive Surgical by 1.4% during the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after acquiring an additional 453,335 shares during the period. Invesco Ltd. raised its stake in Intuitive Surgical by 1.7% during the first quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after purchasing an additional 71,794 shares during the period. Northern Trust Corp boosted its holdings in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock valued at $1,798,465,000 after purchasing an additional 11,988 shares during the last quarter. Wellington Management Group LLP grew its stake in shares of Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock valued at $1,732,975,000 after buying an additional 457,080 shares during the period. Finally, Nuveen LLC acquired a new stake in shares of Intuitive Surgical during the 1st quarter worth approximately $1,715,899,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In related news, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The stock was sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares of the company’s stock, valued at $9,368,059.23. The trade was a 59.69% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the company’s stock in a transaction dated Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president owned 353 shares in the company, valued at approximately $173,845.44. This trade represents a 92.73% decrease in their position. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 in the last 90 days. Company insiders own 0.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have commented on the company. UBS Group lifted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research report on Wednesday, July 23rd. Wall Street Zen lowered shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a report on Friday. Piper Sandler reaffirmed an “overweight” rating and issued a $595.00 target price (up previously from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Royal Bank Of Canada reiterated an “outperform” rating and set a $615.00 price target on shares of Intuitive Surgical in a research report on Tuesday, August 19th. Finally, BTIG Research boosted their price target on shares of Intuitive Surgical from $566.00 to $571.00 and gave the company a “buy” rating in a research note on Wednesday, July 23rd. Thirteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $595.95.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $441.12 on Monday. The firm has a market capitalization of $158.13 billion, a PE ratio of 61.52, a price-to-earnings-growth ratio of 4.62 and a beta of 1.61. The firm’s 50-day moving average is $469.43 and its two-hundred day moving average is $501.66. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, beating the consensus estimate of $1.93 by $0.26. The business had revenue of $2.44 billion during the quarter, compared to analyst estimates of $2.35 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The business’s revenue for the quarter was up 21.4% compared to the same quarter last year. During the same quarter last year, the firm posted $1.78 earnings per share. Analysts expect that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.